The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome.

Plain Language Summary

Examines how Selank affects hemostasis (blood clotting), lipid profile, and blood sugar in a rat model of metabolic syndrome. Metabolic syndrome features hyperglycemia, dyslipidemia, and hypercoagulability. Selank treatment modulated these parameters, suggesting potential metabolic and cardiovascular protective effects beyond its central nervous system actions.